WebOct 3, 2024 · This Schedule 13D amends the Schedule 13D initially filed by Elon Musk (the “Reporting Person”) with the Securities and Exchange Commission on April 5, 2024 with … WebApr 14, 2024 · Institute a moratorium on the acquisition of beneficial ownership of additional equity securities of an issuer by any acquirer required to file a Schedule 13D that would be in effect from the acquisition of a 5% ownership stake until two business days after filing the Schedule 13D; Revise the definition of “beneficial ownership” under Rule ...
SEC Reporting Obligations Under Section 13 and Section 16 of the ...
WebTrustees of General Electric Pension Trust, et al. - ‘SC 13D/A’ on 3/16/98 re: Doubletree Corp - Statement of Acquisition of Beneficial Ownership by an "Active" Investor - Seq. 1 - Amendment to Statement of Acquisition of Beneficial Ownership by an "Active" Investor - Accession Number 0001047469-98-009917 - Filing - SEC WebIf amending a prior Schedule 13D, file a SC 13D/A, or if amending a prior Schedule 13G, file a SC 13G/A. On the main screen: Fill in the Filer CIK and CCC information. Fill in the Subject … reserve bank ocr
SC 13D/A - sec.gov
WebMar 6, 2024 · Background On February 10, 2024, the Securities and Exchange Commission (the “SEC”) proposed amendments to Schedules 13D and 13G relating to beneficial ownership reports (the “Proposed Amendments”). The Securities Exchange Act of 1934 (the “Exchange Act”), Section 13(d), was originally enacted to address the increasing use of … Web13D, the “ Schedule 13D ”), remain in full force and effect. Capitalized terms used herein and not otherwise defined shall have the same meanings ascribed to them in the Original … WebApr 18, 2024 · A person who previously filed a Schedule 13G is generally required to file a Schedule 13D within ten days after it forms the intent to change or influence control of the target, although this requirement does not apply to persons who filed a 13G pursuant to Rule 13d-1(d) (which applies to persons who held their securities before the target ... prosthetic lung